This Winnipeg Free Press article (2.5 minute read), “Throat spray proven effective for fighting cold, flu”, published on November 2, 2017, shares the results of the University of Manitoba Richardson Centre’s study on the effectiveness and safety of InnoTech Nutrition’s Colflex throat spray.
“In the lab, we found this product halted the incubation of staph, strep, e-coli and salmonella bacteria in less than 30 minutes,” Dr. Peter Jones said. “Moreover, our double-blind, randomized clinical trial showed Colflex had no effect on the glucose levels (blood sugar), lipids (cholesterol), or liver enzymes of people who took the supplement over a period of four weeks.”
InnoTech’s CEO, Wayne Friesen, notes in the article that NHPs make health claims for benefits but are often not “put to the test”. While there may not be a vast database of double-blind, randomized, controlled clinical trials on NHPs, there are well documented sources of anecdotal and traditional evidence with decidedly positive and safe outcomes. Often for centuries and, in some cases, for millennia. The growing public demand for a natural health product with longstanding results of efficacy is also a test that many without DBRCTs continue to pass.
Innotech’s Colflex was supported by contemporary science confirming widely established knowledge in natural medicines and practices about the power of essential spice oils.
Unfortunately, the same cannot be said about the safety outcomes of many pharmaceutical cold and flu medications that do go through the same gold standard testing process. For example, acetaminophen, often used for the treatment of colds and reduction of fevers related to the flu, is one of the most common causes of liver failure in the US and Canada.
